Menu
Trizepatide represents a new frontier in diabetes and obesity treatment, offering unprecedented benefits by targeting two incretin pathways.
Get your 12-week supply for:
$1,349.00
More about DripIV’s
• Superior Glycemic Control: Enhances blood sugar management in type 2 diabetes.
• Significant Weight Loss: Promotes weight reduction through dual hormonal action.
• Cardiovascular Health: Potential to improve cardiovascular outcomes in diabetic patients.
• Innovative Treatment: Combines GIP and GLP-1 receptor agonism for enhanced efficacy.
BLEWM © 2024. All Rights Reserved.
